Open the map

Vertex PharmaceuticalsVRTX

Biotech & innovation · NASDAQ · USA

$503.25
Down 0.5% todayClose

Up 11.5% this year and +2.4% since June 26, behind the life science sector at +10.7%. Vertex Pharmaceuticals supplies 2 mapped companies and buys from 1.

Market cap
$128B
This year
+11.5%
1 year
+23.2%
P/E
29.1
P/S
10.2
P/B
6.3

Price vs the life science sector

since Jun 26VRTXLife science sector, equal weight
Vertex Pharmaceuticals (VRTX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. VRTX: +2.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%Jun 26AugSepOct 8VRTX +2.4%Sector +10.7% Vertex Pharmaceuticals (VRTX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. VRTX: +2.4% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%Jun 26AugSepOct 8VRTX+2.4%Sector+10.7%

Supply chain

1 supplier · 2 customers
SUPPLIERS →→ CUSTOMERSIllumina (ILMN)ILMNIllumina−1.2%McKesson (MCK)MCKMcKesson+2.2%The Cigna Group (CI)CIThe Cigna Group+0.9%VRTXVertex Pharmace…

Suppliers 1

Customers 2

Open the full chain →

About Vertex Pharmaceuticals

Cystic fibrosis medicines carry the business. The newer work sits in pain treatment and in cell and gene therapy, where Casgevy belongs.

Theme exposure

BiotechRare diseasesGene therapy exposureGene therapy

Products

  • Cystic fibrosis
  • Pain treatment
  • Cell & gene therapy (Casgevy)

Competitors

  • Other CF players
  • Gene therapy biotechs

Risks

  • Concentration in CF franchise
  • Pipeline execution

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Gilead SciencesGILD+0.2%ModernaMRNA+0.3%RegeneronREGN−0.3%BiogenBIIB−1.7%Alnylam PharmaceuticalsALNY+0.1%United TherapeuticsUTHR−2.2%IncyteINCY−0.6%

Compare VRTX

Side by side with the largest companies in the same segment.

VRTX vs AMGNVRTX vs GILDVRTX vs MRNAVRTX vs REGNVRTX vs BIIBVRTX vs ALNY

See where Vertex Pharmaceuticals sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →